ALDEA Pharmaceuticals
Redwood City · Founded 2011
About ALDEA Pharmaceuticals
ALDEA Pharmaceuticals is developing small-molecule modulators of the aldehyde dehydrogenase enzyme (ALDH) family, to treat toxic aldehyde-related diseases. This proprietary technology represents new product opportunities to address novel targets across multiple therapeutic areas. For example, an ALDH activator compound enhances the detoxification of acetaldehyde in the alcohol metabolism pathway, to treat acute symptoms and to reduce long-term tissue damage and cancer risk. The company was founded in 2011 and headquartered in Redwood City, California.
Company Facts
- Founded: 2011
- Legal name: ALDEA Pharmaceuticals, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $42.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2014)
- Website: aldeapharmaceuticals.com
- Phone: 6502411591
Canonical: https://fsome.com/organization/aldea-pharmaceuticals-8375589 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.